Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-056432

Chief Financial Officer gave up 4,464 shares (to pay taxes)

  • Chief Financial Officer acquired 8,789 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bellemin Jean-Marc Chief Financial Officer 2025-06-02 Option exercise +8,789 64,993 D: show line 1 in the form
Bellemin Jean-Marc Chief Financial Officer 2025-06-02 Shares withheld for taxes −4,464 $1.76 $7,857 60,529 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bellemin Jean-Marc Chief Financial Officer 2025-06-02 Option exercise · Restricted Stock Units −8,789 61,528 D: show line 3 in the form
Loading xslF345X05/tm2517077-1_4seq1.xml…